We are excited to welcome Ole Fuetterer as our new Head of Business Development EU and APAC! Ole is a seasoned biotech CDMO business development professional with over two decades of industry experience. Prior to joining DINAMIQS, he was the Global Head of Business Development at Celonic AG, with responsiblities for licensing, marketing, and alliance management. With his passion for transforming small CDMOs into mature mid-to-large scale entities, through culture, processes, and business growth, he will help bring DINAMIQS to the next level of growth. #growth #strongestteam #businessdevelopment
DINAMIQS
Biotechnologieforschung
Schlieren, Zurich 2.717 Follower:innen
We are bringing AAV viral vector manufacturing, processes and analytics to the global genetic medicine community.
Info
DINAMIQS is a science-driven Contract Development and Manufacturing Organization (CDMO) offering end-to-end viral vector manufacturing solutions. DINAMIQS offers a comprehensive and customized range of manufacturing services, process development, quality control and analytics solutions for genetic medicine companies. It is located in Schlieren-Zurich Bio-Technopark in Switzerland.
- Website
-
http://dinamiqs.com/
Externer Link zu DINAMIQS
- Branche
- Biotechnologieforschung
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Schlieren, Zurich
- Art
- Privatunternehmen
- Gegründet
- 2022
Orte
-
Primär
Wagistrasse 25
Schlieren, Zurich 8952, CH
Beschäftigte von DINAMIQS
-
Daniel Nieper
Chief Strategy Officer at Siegfried Holding AG
-
Dr. Manja Boerman
-
Joe Cox
I help our clients transform possibilities into reality, accelerating the development and commercialization of innovative cell and gene therapies.…
-
Johannes Holzmeister
Chairman & CEO at DiNAQOR AG
Updates
-
Our Chief Technology Officer Eduard Ayuso recently published a paper in Molecular Therapy MCD on analyzing miRNAs in AAV stocks. Read the article to learn more: https://lnkd.in/dmZ-wtqR
Residual microRNAs in AAV vector batches. Take a look at our new article published in Molecular Therapy MCD: https://lnkd.in/emSDu8UT #AAV, #bioproduction, #quality controls
-
We are proud to be among the top players driving innovation in the biotech sector in the greater Zurich area.
🌟 Explore Greater Zurich’s #biotech ecosystem with our new map! 🔬 The Greater Zurich Area is a global hub for biotech and #pharma. This success is fueled by top academic institutions, business-friendly regulations, and a collaborative environment that attracts top researchers and significant investment from across the globe. 🗺️ To provide a snapshot of the vibrant biotech landscape, we have created a detailed map showcasing over 100 key players driving #innovation in the sector. While the overall biotech ecosystem is much larger, this map highlights leading companies, major universities and research labs, as well as industry associations. 🔍 Explore the map below or download it here: https://lnkd.in/d9BmUxkQ. Want to dive deeper into what makes the #GreaterZurichArea a hotspot for biotech? Find out here: https://lnkd.in/dA6YX8yD. #biotechnology #pharmaceutics #technology #whySwitzerland
-
With the BIOSECURE Act on the horizon, small and large pharmaceutical companies contracting with Chinese CDMOs will have to consider alternative suppliers to ensure that gene therapy projects remain uninterrupted. DINAMIQS is your strategic partner to navigate a post-BIOSECURE Act world. Headquartered in Switzerland, with a network in Europe and the US, DINAMIQS' CDMO services guarantee cutting edge scientific expertise, compliance, security, and excellence for your gene therapy programs. Contact our BD teams Joe Cox and vincent zuliani to learn more. #BIOSECURE #SwissQuality #CDMO #Expertise #Compliance
-
-
As a proud member of the MAGIC Consortium, we are pleased to welcome Instituto de Medicina Molecular (iMM) as the newest member. Read the press release to learn more about iMM's expertise and involvement. #partners #AAVvectors #research #genetictherapies
We are thrilled to announce that Instituto de Medicina Molecular (iMM) has joined the MAGIC Consortium to advance research on muscular dystrophies. With the addition of iMM's expertise, we aim to enhance muscle-on-chip models and develop innovative genetic therapies. iMM's involvement includes the Gomes group introducing a novel cellular perspective to the project, significantly advancing the development of disease-specific models. Additionally, iMM will establish two new disease models for centronuclear myopathies, broadening the scope and impact of our research. This partnership aligns with iMM's mission to advance biomedical research and improve clinical care, ultimately benefiting society. The aim of the MAGIC Project is to revolutionize the study and treatment of neuromuscular diseases with cutting-edge approaches and a patient-centric focus. Read the full press release here: https://lnkd.in/eryQi5f9
-
"By integrating analytics as early as possible during the process development, we achieve a comprehensive understanding of the process and product right from the start," says our Chief Technology Officer, Eduard Ayuso. Read the blog to learn how DINAMIQS tackles the key challenges in viral vector manufacturing: https://lnkd.in/dPhdqzxx #expertise #overcomingchallenges #viralvectors #genetherapy
Tackling the key challenges in viral vector manufacturing - Dinamiqs
https://dinamiqs.com
-
We look forward to meeting you on day 2 of #ASGCT! Come visit us at booth 2136 to learn about our vector design, manufacturing and analytical capabilities. #expertise #viralvectors #celltherapy #genetherapy
-
-
It's been an exciting year since we joined the Siegfried network! We've grown our team and capabilities, started the build-out of our new facility, and celebrated joint successes with our clients. We're looking forward continue our journey as the leading science driven CDMO in gene therapy and meeting you at ASGCT in Baltimore this week!
It's been 1 year since Siegfried acquired a majority stake in DINAMIQS to expand our footprint in the biologics space. We're proud to see how DINAMIQS has grown over the past year and are excited for what is still to come! #Growth #CDMO #ViralVectors #Biologics #Acquisition #Anniversary
-
-
From May 7- 11 we're in Baltimore at #ASGCT2024. Schedule a meeting in advance or visit us directly at booth 2136 to learn about our vector design, manufacturing and analytical capabilities. American Society of Gene & Cell Therapy #expertise #viralvectors #celltherapy #genetherapy
-